Cancer Drug Research
The Before & After of Astrocytoma
BEFORE: The above image shows a far advanced astrocytoma of orange size in the left parietal area. The mid line is majorly shifted to the right and with the severe cerebral edema almost closes the right ventricle. Clinically this is a rescue from the front steps of the funeral home.
AFTER: After one 5-day course of chemotherapy with our cancer drug. The patient woke up in 10-14 days. No hematopoetic toxicity. This scan at 6 wks has the mid-line back to normal, there is no mass where the tumor was, and we are seeing the megakarocytes – “the janitor cells” – cleaning up the disintegrated cells of the tumor. The surgical defect is showing.
PATHWAY TO FORMING THE CANCER DRUG PATENT
This is New Medical Science, " THE SCIENCE OF CANCER. " Our drug CONTROLS the "Trigger " to Cancer cell Development. The Goff Hill Limited CANCER DRUG, in a five ( 5 ) day treatment, produces " Complete Disintegration " of the Tumor. Our Cancer Drug is a CURE for Primary Brain Tumors, Breast, Colon, and lung Tumors.
The study was done in 1979-1980. I was not allowed to publish the results and ; therefore the drug was not able to be patented at that time. It is necessary to understand that in the ‘60’s, ‘70’s, ‘80’s, and ‘90’s, ALL Oncology Drugs interfered with a small percentage of the cell cycle and besides being VERY TOXIC, did “ little “ to increase survival time. The evaluation of these drugs in Pre-Clinical Experiments was done in cell cultures where they kill a cell and the dead cell will be found in the culture.
With our drug, we had the clinical evidence of complete cell disintegration which had never been seen before and, as a matter of fact, has NEVER been seen except with our drug. In the ‘80’s and ‘90’s, cell cultures were not as reliable as they are today. I spent many hours and a multitude of “ Tries “ with our drug in Tissue culture and the “ Blind Allies “ remained closed with NO useful results. The drug obviously was totally different from action of other drugs known.
The “ LIGHT “ finally came ON when the “ EGFR “ WAS IN THE EARLY RESEARCH DEVELOPMENT. After spending years in the tissue culture area, and attempting to find Chemical answers, to effectiveness, FINALLY, BY 2005 WE STARTED TO FIND THAT ANY CONTROL OF EGFR will NOT work in tissue culture.
My effort over the next three (3) years was concentrated on the Chemical Trigger mechanisms, which in 2008 were worked out and we were able then to develop the required information for the Cancer Drug Patent. This is TRULY NEW SCIENCE and I will be” most Happy” to discuss the Science of both Drugs and include Scientific and Chemical” Factual” information in a Presentation.